Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Joyce Lee

Concepts (351)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Diseases, Interstitial
66
2025
660
12.930
 Why?
Idiopathic Pulmonary Fibrosis
63
2026
691
11.320
 Why?
Arthritis, Rheumatoid
25
2025
1169
4.750
 Why?
Scleroderma, Systemic
10
2025
123
2.440
 Why?
Immunosuppressive Agents
9
2025
846
2.050
 Why?
Connective Tissue Diseases
9
2021
84
1.710
 Why?
Lung
28
2025
4109
1.640
 Why?
Mucin-5B
5
2025
234
1.540
 Why?
Vital Capacity
19
2025
290
1.530
 Why?
Autoimmune Diseases
11
2025
463
1.480
 Why?
Disease Progression
14
2025
2847
1.380
 Why?
Tomography, X-Ray Computed
27
2025
2730
1.380
 Why?
Gastroesophageal Reflux
5
2020
236
1.240
 Why?
Rheumatic Diseases
5
2024
97
1.200
 Why?
Pulmonary Fibrosis
10
2025
395
1.150
 Why?
Prognosis
23
2025
4282
1.020
 Why?
Humans
134
2026
144759
1.000
 Why?
Myositis
5
2025
57
0.990
 Why?
Alveolitis, Extrinsic Allergic
6
2022
93
0.970
 Why?
Respiratory Aspiration
4
2020
32
0.920
 Why?
Biomarkers
12
2025
4271
0.900
 Why?
Telomere
3
2025
288
0.880
 Why?
Middle Aged
58
2026
35875
0.860
 Why?
Aged
54
2026
25913
0.860
 Why?
Idiopathic Interstitial Pneumonias
4
2019
44
0.840
 Why?
Quality of Life
4
2024
3185
0.820
 Why?
Telomerase
2
2023
248
0.760
 Why?
Carcinoma, Hepatocellular
5
2025
370
0.750
 Why?
Pulmonary Surfactants
1
2023
102
0.750
 Why?
Histamine H2 Antagonists
2
2013
23
0.730
 Why?
Cryptogenic Organizing Pneumonia
1
2022
19
0.730
 Why?
Glucocorticoids
3
2024
535
0.720
 Why?
Matrix Metalloproteinase 7
1
2021
25
0.710
 Why?
Respiratory Function Tests
11
2025
547
0.690
 Why?
Proton Pump Inhibitors
2
2013
109
0.680
 Why?
Male
71
2026
72315
0.680
 Why?
Adrenal Cortex Hormones
3
2021
478
0.660
 Why?
Proteomics
3
2025
1195
0.650
 Why?
Rheumatology
5
2024
133
0.640
 Why?
Lung Transplantation
10
2025
338
0.630
 Why?
Female
70
2026
78271
0.620
 Why?
Diagnosis, Differential
9
2025
1489
0.610
 Why?
Cellular Senescence
1
2021
226
0.570
 Why?
Telomere Shortening
3
2025
19
0.550
 Why?
Genetic Predisposition to Disease
3
2026
2363
0.540
 Why?
Liver Neoplasms
5
2025
780
0.530
 Why?
Prospective Studies
13
2025
7990
0.520
 Why?
Severity of Illness Index
10
2025
2925
0.500
 Why?
Abatacept
3
2025
56
0.500
 Why?
Dyspnea
5
2023
251
0.480
 Why?
Patient Satisfaction
2
2021
704
0.480
 Why?
Forecasting
1
2017
391
0.460
 Why?
Survival Rate
11
2025
2089
0.460
 Why?
Risk Assessment
10
2021
3671
0.460
 Why?
Longitudinal Studies
8
2017
2947
0.410
 Why?
Cohort Studies
13
2025
5960
0.410
 Why?
Azathioprine
2
2024
49
0.390
 Why?
Patient Education as Topic
2
2016
780
0.390
 Why?
Pulmonary Diffusing Capacity
5
2020
78
0.380
 Why?
Early Diagnosis
2
2025
249
0.380
 Why?
Precision Medicine
1
2017
457
0.380
 Why?
Rituximab
2
2024
209
0.370
 Why?
Hypertension, Pulmonary
3
2022
1980
0.360
 Why?
Pepsin A
1
2011
18
0.360
 Why?
Antirheumatic Agents
4
2024
304
0.350
 Why?
Comprehensive Health Care
1
2011
22
0.340
 Why?
Fundoplication
1
2011
54
0.340
 Why?
Sleep Apnea, Obstructive
1
2015
300
0.330
 Why?
Veterans
4
2023
1603
0.320
 Why?
Carbon Monoxide
4
2019
82
0.320
 Why?
Bronchoalveolar Lavage Fluid
2
2011
636
0.310
 Why?
Endotoxins
1
2010
221
0.310
 Why?
Forced Expiratory Volume
4
2025
449
0.300
 Why?
Sirolimus
1
2011
281
0.300
 Why?
Proportional Hazards Models
7
2024
1325
0.300
 Why?
Phenotype
6
2025
3162
0.290
 Why?
Anti-Bacterial Agents
1
2019
1907
0.280
 Why?
Walk Test
2
2025
80
0.280
 Why?
United States
17
2025
15966
0.270
 Why?
Retrospective Studies
16
2024
17066
0.270
 Why?
Emphysema
2
2022
100
0.270
 Why?
Mycophenolic Acid
3
2024
120
0.260
 Why?
Acute Lung Injury
1
2010
303
0.260
 Why?
Risk Factors
11
2026
10779
0.250
 Why?
Lung Diseases
3
2020
787
0.250
 Why?
Comorbidity
5
2015
1658
0.250
 Why?
Autoantibodies
2
2015
1501
0.240
 Why?
Immunotherapy
3
2025
653
0.230
 Why?
Prevalence
5
2022
2834
0.230
 Why?
Cancer-Associated Fibroblasts
1
2025
23
0.230
 Why?
Depression
1
2015
1558
0.230
 Why?
Predictive Value of Tests
4
2017
2115
0.230
 Why?
Pyridones
2
2024
199
0.220
 Why?
Pulmonologists
1
2025
14
0.220
 Why?
Yttrium Radioisotopes
2
2023
64
0.220
 Why?
Mutation
3
2023
4089
0.220
 Why?
Antineoplastic Agents, Phytogenic
1
2026
177
0.220
 Why?
Paclitaxel
1
2026
255
0.220
 Why?
Sex Factors
4
2020
2112
0.220
 Why?
Aged, 80 and over
10
2024
8265
0.210
 Why?
Case-Control Studies
6
2021
3604
0.210
 Why?
Endothelium, Vascular
1
2010
965
0.200
 Why?
Spirometry
3
2025
231
0.200
 Why?
Biopsy, Needle
3
2019
183
0.200
 Why?
Chronic Disease
6
2020
1813
0.200
 Why?
Exercise Tolerance
1
2025
283
0.200
 Why?
Pulmonary Emphysema
2
2025
275
0.200
 Why?
Sputum
1
2025
308
0.200
 Why?
Blood Proteins
1
2025
249
0.190
 Why?
Urinary Bladder Neoplasms
1
2026
255
0.190
 Why?
Fatty Liver
1
2025
251
0.190
 Why?
Treatment Outcome
8
2025
11679
0.190
 Why?
Polychlorinated Dibenzodioxins
1
2022
10
0.190
 Why?
T-Lymphocytes, Regulatory
1
2025
389
0.190
 Why?
Fibrosis
3
2022
548
0.190
 Why?
Transforming Growth Factor beta
1
2025
479
0.180
 Why?
Indoles
2
2024
501
0.180
 Why?
Genotype
2
2025
1833
0.180
 Why?
Adult
19
2025
40449
0.180
 Why?
Genetic Testing
1
2025
478
0.180
 Why?
Self Care
2
2017
389
0.170
 Why?
Monocytes
2
2021
538
0.170
 Why?
Organizational Objectives
1
2021
66
0.170
 Why?
Incidence
5
2023
2879
0.170
 Why?
Genetic Markers
1
2022
331
0.170
 Why?
Nursing Research
1
2021
53
0.170
 Why?
Societies, Medical
5
2025
887
0.160
 Why?
Chemoembolization, Therapeutic
1
2021
89
0.160
 Why?
Kaplan-Meier Estimate
5
2017
965
0.160
 Why?
Smoking
3
2024
1472
0.160
 Why?
Patient Outcome Assessment
1
2021
134
0.160
 Why?
Chemokine CX3CL1
1
2020
25
0.160
 Why?
Immunohistochemistry
3
2019
1716
0.160
 Why?
Disease Models, Animal
1
2010
4557
0.150
 Why?
Survival Analysis
3
2012
1382
0.150
 Why?
Models, Organizational
1
2020
144
0.150
 Why?
Disease Management
4
2018
645
0.150
 Why?
Myositis, Inclusion Body
1
2019
11
0.150
 Why?
Graft Rejection
2
2020
540
0.150
 Why?
Radiography
2
2011
844
0.150
 Why?
Wnt-5a Protein
1
2018
24
0.140
 Why?
Gain of Function Mutation
1
2018
36
0.140
 Why?
Body Weight
1
2022
976
0.140
 Why?
Immunity, Innate
1
2024
846
0.140
 Why?
Ambulatory Care Facilities
1
2020
265
0.140
 Why?
Signal Transduction
2
2023
5226
0.130
 Why?
Focus Groups
2
2020
573
0.130
 Why?
Randomized Controlled Trials as Topic
1
2024
1720
0.130
 Why?
International Cooperation
1
2017
198
0.130
 Why?
Weight Loss
1
2022
836
0.130
 Why?
Myofibroblasts
1
2018
143
0.120
 Why?
Amino Acyl-tRNA Synthetases
1
2016
32
0.120
 Why?
Health Status Indicators
1
2017
166
0.120
 Why?
Women's Health
1
2018
310
0.120
 Why?
Extracellular Vesicles
1
2018
171
0.120
 Why?
Patient-Centered Care
1
2021
544
0.120
 Why?
Tomography Scanners, X-Ray Computed
1
2015
21
0.120
 Why?
Practice Patterns, Physicians'
1
2025
1356
0.120
 Why?
Acute Disease
3
2016
1030
0.110
 Why?
Follow-Up Studies
4
2019
5408
0.110
 Why?
Sarcoidosis
1
2017
160
0.110
 Why?
Cause of Death
1
2017
471
0.110
 Why?
Pulmonary Medicine
1
2015
79
0.110
 Why?
Antibiotic Prophylaxis
1
2016
129
0.110
 Why?
Sleep Wake Disorders
1
2018
301
0.110
 Why?
Nails
1
2014
13
0.110
 Why?
Hyperpigmentation
1
2014
27
0.110
 Why?
Hospitalization
1
2025
2433
0.110
 Why?
Bronchodilator Agents
1
2015
182
0.100
 Why?
Body Mass Index
1
2022
2438
0.100
 Why?
Oxygen Inhalation Therapy
1
2016
182
0.100
 Why?
Laparoscopy
1
2018
475
0.100
 Why?
Arsenic
1
2014
66
0.100
 Why?
Gene Expression Profiling
1
2020
1782
0.100
 Why?
Interleukin-13
1
2014
144
0.100
 Why?
Diagnostic Imaging
1
2016
338
0.100
 Why?
Age Factors
3
2019
3333
0.100
 Why?
Keratin-18
1
2012
12
0.100
 Why?
Counseling
1
2016
408
0.100
 Why?
Biopsy
4
2018
1075
0.090
 Why?
Cystic Fibrosis
1
2023
1158
0.090
 Why?
Autoimmunity
2
2015
926
0.090
 Why?
Interviews as Topic
1
2016
901
0.090
 Why?
Microspheres
2
2023
142
0.090
 Why?
Maternal Exposure
1
2014
213
0.090
 Why?
Fatigue
1
2014
366
0.090
 Why?
Sjogren's Syndrome
2
2024
37
0.090
 Why?
Age Distribution
3
2019
403
0.090
 Why?
Time Factors
2
2024
7173
0.080
 Why?
Dermatitis, Atopic
1
2014
321
0.080
 Why?
Algorithms
2
2016
1837
0.080
 Why?
Everolimus
1
2011
111
0.080
 Why?
Epithelial Cells
2
2014
1125
0.080
 Why?
Programmed Cell Death 1 Receptor
2
2023
264
0.080
 Why?
Tumor Microenvironment
2
2025
732
0.080
 Why?
Sodium-Potassium-Exchanging ATPase
1
2010
56
0.080
 Why?
Animals
7
2025
38058
0.080
 Why?
Goals
1
2011
183
0.080
 Why?
Fetus
1
2014
803
0.080
 Why?
Leukocytes
2
2025
295
0.070
 Why?
Delphi Technique
2
2022
329
0.070
 Why?
Alveolar Epithelial Cells
1
2010
120
0.070
 Why?
Singapore
2
2021
27
0.070
 Why?
Sensitivity and Specificity
1
2013
1985
0.070
 Why?
Health Status
1
2014
836
0.070
 Why?
Virus Diseases
1
2011
216
0.070
 Why?
Qualitative Research
1
2016
1671
0.070
 Why?
Syndrome
2
2022
380
0.070
 Why?
Models, Statistical
1
2012
681
0.070
 Why?
Proto-Oncogene Proteins c-akt
1
2010
436
0.070
 Why?
Multivariate Analysis
2
2025
1539
0.070
 Why?
DNA
1
2014
1463
0.060
 Why?
Pulmonary Alveoli
2
2025
383
0.060
 Why?
Antibodies, Monoclonal
1
2014
1519
0.060
 Why?
Micelles
1
2026
40
0.060
 Why?
Cell Membrane
1
2010
706
0.060
 Why?
Internationality
2
2017
156
0.060
 Why?
Japan
1
2026
143
0.060
 Why?
France
1
2025
40
0.060
 Why?
Mass Screening
2
2024
1347
0.060
 Why?
Pulmonary Surfactant-Associated Protein D
1
2025
29
0.060
 Why?
Promoter Regions, Genetic
2
2021
1257
0.060
 Why?
Methotrexate
2
2021
240
0.060
 Why?
Logistic Models
2
2025
2117
0.060
 Why?
Genetic Loci
1
2026
261
0.050
 Why?
Cyclophosphamide
1
2025
266
0.050
 Why?
Mixed Connective Tissue Disease
1
2024
9
0.050
 Why?
Pandemics
2
2024
1694
0.050
 Why?
Prednisone
2
2019
221
0.050
 Why?
Sex Distribution
2
2015
386
0.050
 Why?
Mice
3
2025
18339
0.050
 Why?
Professional Practice Gaps
1
2023
15
0.050
 Why?
Demography
1
2024
288
0.050
 Why?
Chromosome Deletion
1
2023
124
0.050
 Why?
Adaptive Immunity
1
2024
169
0.050
 Why?
CD3 Complex
1
2023
111
0.050
 Why?
Palliative Care
1
2011
1002
0.050
 Why?
Agent Orange
1
2022
3
0.050
 Why?
2,4,5-Trichlorophenoxyacetic Acid
1
2022
3
0.050
 Why?
2,4-Dichlorophenoxyacetic Acid
1
2022
14
0.050
 Why?
CTLA-4 Antigen
1
2023
104
0.050
 Why?
Antibody Formation
1
2024
294
0.050
 Why?
Respiratory Mucosa
1
2025
322
0.040
 Why?
Exome
1
2023
227
0.040
 Why?
Whole Genome Sequencing
1
2023
182
0.040
 Why?
Probability
1
2022
310
0.040
 Why?
Patient Reported Outcome Measures
1
2025
488
0.040
 Why?
Administration, Intravenous
1
2021
170
0.040
 Why?
Double-Blind Method
1
2025
2029
0.040
 Why?
Family
1
2025
679
0.040
 Why?
Leukocytes, Mononuclear
1
2023
573
0.040
 Why?
Evidence-Based Medicine
1
2024
732
0.040
 Why?
CX3C Chemokine Receptor 1
1
2020
19
0.040
 Why?
Bayes Theorem
1
2022
433
0.040
 Why?
Total Lung Capacity
1
2019
29
0.040
 Why?
Pilot Projects
1
2025
1886
0.040
 Why?
Immunologic Factors
1
2022
255
0.040
 Why?
Allografts
1
2020
150
0.040
 Why?
Drug Discovery
1
2020
155
0.040
 Why?
Antibodies, Viral
1
2024
672
0.040
 Why?
Mice, Inbred C57BL
1
2010
5992
0.040
 Why?
Safety
1
2021
356
0.040
 Why?
Genome-Wide Association Study
1
2026
1406
0.040
 Why?
Cross-Sectional Studies
2
2025
5868
0.040
 Why?
Ireland
1
2019
32
0.040
 Why?
Fibroblasts
1
2025
1034
0.040
 Why?
Embolization, Therapeutic
1
2021
242
0.040
 Why?
Dermatomyositis
1
2019
24
0.040
 Why?
Insulin
1
2010
2507
0.040
 Why?
Echocardiography
1
2022
652
0.040
 Why?
Polymorphism, Single Nucleotide
1
2026
2145
0.040
 Why?
Rare Diseases
1
2019
113
0.040
 Why?
Combined Modality Therapy
1
2021
1266
0.030
 Why?
Intention to Treat Analysis
1
2018
80
0.030
 Why?
Hydrogen-Ion Concentration
1
2020
561
0.030
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2018
103
0.030
 Why?
Behavior
1
2018
91
0.030
 Why?
Education
1
2018
104
0.030
 Why?
United Kingdom
1
2019
338
0.030
 Why?
Morbidity
1
2018
323
0.030
 Why?
Sleep Apnea Syndromes
1
2018
97
0.030
 Why?
Medicare
1
2023
886
0.030
 Why?
CD8-Positive T-Lymphocytes
1
2023
917
0.030
 Why?
Linear Models
1
2019
854
0.030
 Why?
Registries
1
2025
2385
0.030
 Why?
Antibodies, Antinuclear
1
2016
62
0.030
 Why?
Comprehension
1
2018
180
0.030
 Why?
Muscle Strength
1
2019
330
0.030
 Why?
Flow Cytometry
1
2020
1173
0.030
 Why?
Odds Ratio
1
2018
1075
0.030
 Why?
California
1
2017
475
0.030
 Why?
Gene Expression
1
2020
1490
0.030
 Why?
Evaluation Studies as Topic
1
2015
166
0.030
 Why?
Global Health
1
2018
401
0.030
 Why?
Pneumonia, Aspiration
1
2015
16
0.030
 Why?
Monitoring, Physiologic
1
2017
289
0.030
 Why?
Vaccination
1
2024
1423
0.030
 Why?
Recovery of Function
1
2019
707
0.030
 Why?
Regression Analysis
1
2017
1003
0.030
 Why?
Bronchiolitis Obliterans
1
2015
66
0.030
 Why?
Sampling Studies
1
2014
99
0.030
 Why?
San Francisco
1
2014
60
0.030
 Why?
Chicago
1
2014
61
0.030
 Why?
Europe
1
2015
412
0.030
 Why?
Neck
1
2014
108
0.030
 Why?
Patient Acuity
1
2013
47
0.030
 Why?
Endothelial Cells
1
2020
869
0.020
 Why?
Texas
1
2014
278
0.020
 Why?
Mice, SCID
1
2014
369
0.020
 Why?
Observational Studies as Topic
1
2013
129
0.020
 Why?
Enzyme Inhibitors
1
2016
824
0.020
 Why?
Protein Kinase Inhibitors
1
2019
969
0.020
 Why?
Developing Countries
1
2014
318
0.020
 Why?
Young Adult
2
2022
14105
0.020
 Why?
Surveys and Questionnaires
1
2025
6048
0.020
 Why?
Endoplasmic Reticulum Stress
1
2012
120
0.020
 Why?
Torque teno virus
1
2011
1
0.020
 Why?
Academic Medical Centers
1
2014
547
0.020
 Why?
DNA Virus Infections
1
2011
3
0.020
 Why?
Up-Regulation
1
2014
851
0.020
 Why?
Cells, Cultured
1
2018
4154
0.020
 Why?
Molecular Targeted Therapy
1
2014
432
0.020
 Why?
Pulmonary Disease, Chronic Obstructive
1
2018
920
0.020
 Why?
Microarray Analysis
1
2011
117
0.020
 Why?
Mass Spectrometry
1
2014
750
0.020
 Why?
Models, Theoretical
1
2014
582
0.020
 Why?
Colorado
1
2020
4564
0.020
 Why?
Subcellular Fractions
1
2010
74
0.020
 Why?
Body Fluids
1
2010
70
0.020
 Why?
GTPase-Activating Proteins
1
2010
82
0.020
 Why?
Practice Guidelines as Topic
1
2017
1560
0.020
 Why?
rab GTP-Binding Proteins
1
2010
76
0.020
 Why?
Adolescent
2
2022
22428
0.020
 Why?
Reproducibility of Results
1
2017
3409
0.020
 Why?
Inflammation
1
2020
2878
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
758
0.020
 Why?
Models, Biological
1
2016
1821
0.020
 Why?
Protein Transport
1
2010
441
0.020
 Why?
Phosphatidylinositol 3-Kinases
1
2010
380
0.020
 Why?
Polymerase Chain Reaction
1
2011
1054
0.020
 Why?
Sequence Analysis, DNA
1
2011
824
0.020
 Why?
Telemedicine
1
2017
945
0.020
 Why?
Cattle
1
2010
1000
0.020
 Why?
Asthma
1
2018
1767
0.020
 Why?
Respiratory Tract Infections
1
2011
397
0.020
 Why?
Rats, Sprague-Dawley
1
2010
2527
0.010
 Why?
Apoptosis
1
2012
2430
0.010
 Why?
Rats
1
2010
5597
0.010
 Why?
Pregnancy
1
2014
7190
0.010
 Why?
Infant
1
2014
10034
0.010
 Why?
Child
1
2014
22633
0.010
 Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (351) concept(s)
_
Co-Authors Expand Description
See all (33) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)